Trial
NCT02994771
A Phase I Study With Lymfactin® in the Treatment of Patients With Secondary Lymphedema
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Herantis Pharma Plc.
Collaborators
—
Condition
Secondary Lymphedema
Intervention
Lymfactin® [1 x 10E10 vp]
Why stopped
Lack of efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-04-24